中国实验血液学杂志2024,Vol.32Issue(2) :476-482.DOI:10.19746/j.cnki.issn1009-2137.2024.02.024

NVP-BEZ235逆转伯基特淋巴瘤RAJI细胞阿霉素耐药的研究

Reversal Effect of NVP-BEZ235 on Doxorubicin-Resistance in Burkitt Lymphoma RAJI Cell Line

李纯团 朱雄鹏 王少雄 彭群艺 郑艳 刘生全 卢旭东 王永彬 翁丹 王丹
中国实验血液学杂志2024,Vol.32Issue(2) :476-482.DOI:10.19746/j.cnki.issn1009-2137.2024.02.024

NVP-BEZ235逆转伯基特淋巴瘤RAJI细胞阿霉素耐药的研究

Reversal Effect of NVP-BEZ235 on Doxorubicin-Resistance in Burkitt Lymphoma RAJI Cell Line

李纯团 1朱雄鹏 1王少雄 1彭群艺 1郑艳 1刘生全 1卢旭东 2王永彬 2翁丹 2王丹2
扫码查看

作者信息

  • 1. 福建医科大学附属泉州第一医院血液内科,福建泉州 362200
  • 2. 福建医科大学临床医学部,福建福州 350004
  • 折叠

摘要

目的:研究NVP-BEZ23对耐阿霉素细胞株RAJI/DOX的逆转耐药作用.方法:利用浓度梯度法诱导耐阿霉素细胞株RAJI/DOX;Western blot测定各组细胞Pgp、p-AKT、p-mTOR蛋白水平;MTT法检测细胞抑制率,SPSS软件测定IC50.结果:成功诱导出耐阿霉素细胞株RAJI/DOX.耐阿霉素细胞株RAJI/DOX中Pgp、p-AKT、p-mTOR蛋白水平高于亲本细胞RAJI.NVP-BEZ235可引起耐阿霉素细胞株RAJI/DOX中p-AKT、p-mTOR蛋白水平下降.NVP-BEZ235能够抑制耐阿霉素细胞株RAJI/DOX增殖,与阿霉素具有协同作用.结论:PI3K/AKT/mTOR通道在耐阿霉素伯基特淋巴瘤细胞中进一步活化;NVP-BEZ235通过抑制PI3K/AKT/mTOR信号通道活化,能够与阿霉素协同抑制伯基特淋巴瘤耐药细胞,逆转伯基特淋巴瘤耐药细胞对阿霉素的耐药性.

Abstract

Objective:To study the reversal effect of NVP-BEZ235 on doxorubicin resistance in Burkitt lymphoma RAJI cell line.Methods:The doxorubicin-resistant cell line was induced by treating RAJI cells with a concentration gradient of doxorubicin.The levels of Pgp,p-AKT,and p-mTOR in cells were detected by Western blot.Cell viability was detected by MTT assay.IC50 was computed by SPSS.Results:The doxorubicin-resistant Burkitt lymphoma cell line,RAJI/DOX,was established successfully.The expression of Pgp and the phosphorylation levels of AKT and mTOR in RAJI/DOX cell line were both higher than those in RAJI cell line.NVP-BEZ235 downregulated the phosphorylation levels of AKT and mTOR in RAJI/DOX cell line.NVP-BEZ235 inhibited the proliferation of RAJI/DOX cell line,and the effect was obvious when it was cooperated with doxorubicin.Conclusion:The constitutive activation of PI3K/AKT/mTOR pathway of RAJI/DOX cell line was more serious than RAJI cell line.NVP-BEZ235 reversed doxorubicin resistance of RAJI/DOX cell line by inhibiting the PI3K/AKT/mTOR signal pathway.

关键词

NVP-BEZ235/伯基特淋巴瘤/阿霉素耐药/逆转

Key words

NVP-BEZ235/Burkitt lymphoma/doxorubicin-resistance/reversal effect

引用本文复制引用

基金项目

福建省自然科学基金(2022J011461)

出版年

2024
中国实验血液学杂志
中国病理生理学会

中国实验血液学杂志

CSTPCD北大核心
影响因子:0.988
ISSN:1009-2137
参考文献量24
段落导航相关论文